Aurobindo Pharma Limited (NSE:AUROPHARMA)

Aurobindo Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	71,914	55,690	33,935	43,963	41,625
Short-Term Investments	-	26,463	26,323	29,329	18,364	4,038
Trading Asset Securities	-	7,472	0.1	0.1	0.1	0.1
Cash & Short-Term Investments	105,849	105,849	82,013	63,264	62,327	45,663
Cash Growth	28.53%	29.06%	29.64%	1.50%	36.49%	-18.92%
Accounts Receivable	-	70,944	57,459	48,167	44,664	40,123
Other Receivables	-	3,700	6,402	5,150	5,356	3,619
Receivables	-	74,822	64,016	53,446	50,144	43,869
Inventory	-	120,529	105,437	98,082	85,112	75,539
Other Current Assets	-	25,887	20,158	27,265	17,874	16,157
Total Current Assets	-	327,088	271,625	242,056	215,457	181,227
Property, Plant & Equipment	-	173,388	154,554	142,849	124,918	106,660
Long-Term Investments	-	3,039	2,517	3,216	3,917	6,183
Goodwill	-	8,002	6,180	5,952	5,961	4,754
Other Intangible Assets	-	43,016	34,660	32,874	31,279	29,587
Long-Term Accounts Receivable	-	-	1,083	-	-	-
Long-Term Deferred Tax Assets	-	14,836	12,930	12,126	6,775	2,886
Long-Term Deferred Charges	-	1,797	1,548	1,941	1,980	1,792
Other Long-Term Assets	-	13,782	12,687	9,643	8,558	6,065
Total Assets	-	585,022	497,850	450,715	398,900	339,217

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	55,673	41,889	44,542	38,713	27,031
Accrued Expenses	-	32,067	23,696	17,924	16,378	12,165
Short-Term Debt	-	60,796	54,702	41,685	42,304	21,178
Current Portion of Long-Term Debt	-	7,938	9,098	117.8	121.3	57.3
Current Portion of Leases	-	1,037	819.8	798.8	1,032	1,599
Current Income Taxes Payable	-	2,106	2,849	2,490	2,116	580.3
Current Unearned Revenue	-	1,445	1,038	2,703	3,889	5,679
Other Current Liabilities	-	19,328	12,731	11,731	10,385	13,272
Total Current Liabilities	-	180,390	146,823	121,991	114,938	81,560
Long-Term Debt	-	8,028	15,617	21,349	6,190	2,492
Long-Term Leases	-	2,929	2,392	2,525	3,215	3,186
Long-Term Unearned Revenue	-	530.7	475.7	363.5	-	-
Pension & Post-Retirement Benefits	-	1,776	1,009	747.4	651.6	605
Long-Term Deferred Tax Liabilities	-	3,060	3,033	3,566	3,896	4,110
Other Long-Term Liabilities	-	9,480	2,032	1,665	1,491	1,524
Total Liabilities	-	206,193	171,380	152,207	130,381	93,477

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	580.8	580.8	585.9	585.9	585.9
Additional Paid-In Capital	-	751.1	751.1	4,179	4,179	4,179
Retained Earnings	-	337,245	304,474	276,146	247,236	233,322
Comprehensive Income & Other	-	40,333	20,728	17,517	16,398	7,674
Total Common Equity	378,910	378,910	326,533	298,428	268,399	245,760
Minority Interest	-	-81.6	-63.9	80	120	-19.3
Shareholders' Equity	378,828	378,828	326,469	298,508	268,519	245,741
Total Liabilities & Equity	-	585,022	497,850	450,715	398,900	339,217

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	80,728	80,728	82,629	66,476	52,862	28,513
Net Cash (Debt)	25,121	25,121	-615.9	-3,213	9,465	17,150
Net Cash Growth	-	-	-	-	-44.81%	486.55%
Net Cash Per Share	43.30	43.25	-1.06	-5.48	16.15	29.27
Filing Date Shares Outstanding	578.14	580.8	580.8	585.94	585.94	585.94
Total Common Shares Outstanding	578.14	580.8	580.8	585.94	585.94	585.94
Working Capital	-	146,697	124,801	120,065	100,519	99,667
Book Value Per Share	652.39	652.39	562.21	509.32	458.07	419.43
Tangible Book Value	327,892	327,892	285,694	259,602	231,159	211,419
Tangible Book Value Per Share	564.55	564.55	491.90	443.05	394.51	360.82
Land	-	10,508	8,761	8,686	8,303	6,518
Buildings	-	53,614	45,015	46,978	32,564	25,645
Machinery	-	152,465	128,416	119,040	88,308	76,809
Construction In Progress	-	30,088	32,660	27,394	44,964	29,376

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error